In patients with type 2 diabetes, the circulating GPIHBP1 levels might not correlate well with triglyceride‐rich lipoproteins, and rather well‐reflect the microvascular complications, such diabetic retinopathy and diabetic kidney disease. This evidence concerns the gene GPIHBP1 and type 2 diabetes mellitus.